Artwork

内容由Richard Jacobs提供。所有播客内容(包括剧集、图形和播客描述)均由 Richard Jacobs 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Neurodegenerative Diseases and Optic Neuropathy Treatments for Blinding Conditions Explained By Dr. Bernard Gilly

28:51
 
分享
 

Manage episode 295121418 series 2469176
内容由Richard Jacobs提供。所有播客内容(包括剧集、图形和播客描述)均由 Richard Jacobs 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

How can historically misunderstood retinal neurodegenerative diseases be researched and treated? New discoveries may lead to continuing advancements in treatment for previously thought to be untreatable ailments. Listen in to learn:

  • How treatment is targeted at specific cells
  • How functions in the eye can be swapped between parts
  • How the optogenetic process works

Dr. Bernard Gilly, The CEO and Co-Founder of GenSight Biologics discusses his work trying to cure blinding diseases and the development of LUMEVOQ.

By studying genetic therapies and root causes of optical degenerative diseases, patients who have been blinded by their condition can seek treatment to regain partial vision. Though it is challenging to continue studying improving patients, the therapeutic techniques continue to be improved, and results remain promising.

Though treatments and further research have been delayed, the first patient has received treatment and has regained fundamental visual function. This is promising for the future of macular and retinal degeneration treatments.

To learn more, visit gensight-biologics.com. Episode also available on Apple Podcasts: apple.co/30PvU9C

  continue reading

3743集单集

Artwork
icon分享
 
Manage episode 295121418 series 2469176
内容由Richard Jacobs提供。所有播客内容(包括剧集、图形和播客描述)均由 Richard Jacobs 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

How can historically misunderstood retinal neurodegenerative diseases be researched and treated? New discoveries may lead to continuing advancements in treatment for previously thought to be untreatable ailments. Listen in to learn:

  • How treatment is targeted at specific cells
  • How functions in the eye can be swapped between parts
  • How the optogenetic process works

Dr. Bernard Gilly, The CEO and Co-Founder of GenSight Biologics discusses his work trying to cure blinding diseases and the development of LUMEVOQ.

By studying genetic therapies and root causes of optical degenerative diseases, patients who have been blinded by their condition can seek treatment to regain partial vision. Though it is challenging to continue studying improving patients, the therapeutic techniques continue to be improved, and results remain promising.

Though treatments and further research have been delayed, the first patient has received treatment and has regained fundamental visual function. This is promising for the future of macular and retinal degeneration treatments.

To learn more, visit gensight-biologics.com. Episode also available on Apple Podcasts: apple.co/30PvU9C

  continue reading

3743集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南